We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
AGNC Investment
AGNC
$12.9B
| – | – |
-17,942
| Closed | -$336K |
|
|
AIV
952
Aimco
AIV
$383M
| – | – |
-372,052
| Closed | -$1.83M |
|
953
Assurant
AIZ
$14.3B
| – | – |
-3,695
| Closed | -$292K |
|
954
Align Technology
ALGN
$12.3B
| – | – |
-31,329
| Closed | -$1.78M |
|
955
Alaska Air
ALK
$5.58B
| – | – |
-242,352
| Closed | -$19.3M |
|
956
Abercrombie & Fitch
ANF
$5B
| – | – |
-15,766
| Closed | -$334K |
|
957
A.O. Smith
AOS
$8.7B
| – | – |
-15,734
| Closed | -$513K |
|
958
Ashland
ASH
$3.5B
| – | – |
-16,501
| Closed | -$812K |
|
|
ASRT
959
DELISTED
Assertio
ASRT
| – | – |
-8,787
| Closed | -$9.94M |
|
960
AptarGroup
ATR
$8.61B
| – | – |
-110,877
| Closed | -$7.31M |
|
961
AtriCure
ATRC
$2.11B
| – | – |
-43,450
| Closed | -$952K |
|
962
Broadcom
AVGO
$2.04T
| – | – |
-86,330
| Closed | -$1.08M |
|
|
AVNS
963
DELISTED
Avanos Medical
AVNS
| – | – |
-25,699
| Closed | -$731K |
|
|
AXON
964
Axon Enterprise
AXON
$46.4B
| – | – |
-177,144
| Closed | -$3.9M |
|
965
AstraZeneca
AZN
$250B
| – | – |
-6,804
| Closed | -$433K |
|
966
Bath & Body Works
BBWI
$4.1B
| – | – |
-19,655
| Closed | -$1.43M |
|
967
Brink's
BCO
$4.62B
| – | – |
-13,629
| Closed | -$368K |
|
968
Barclays
BCS
$94.1B
| – | – |
-50,327
| Closed | -$694K |
|
969
Bunge Global
BG
$20.8B
| – | – |
-16,929
| Closed | -$1.24M |
|
970
Brookfield
BN
$108B
| – | – |
-36,981
| Closed | -$408K |
|
971
BP
BP
$107B
| – | – |
-15,660
| Closed | -$403K |
|
972
Broadridge
BR
$19B
| – | – |
-82,246
| Closed | -$4.55M |
|
973
Boston Scientific
BSX
$71.5B
| – | – |
-688,967
| Closed | -$11.3M |
|
974
Baytex Energy
BTE
$2.92B
| – | – |
-13,848
| Closed | -$44K |
|
975
Avis
CAR
$5.02B
| – | – |
-20,996
| Closed | -$917K |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.